|
"陳昆鋒"的相关文件
显示项目 1-25 / 30 (共2页)
1 2 > >>
每页显示[10|25|50]项目
| 臺大學術典藏 |
2018-09-10T15:18:57Z |
Sorafenib and its derivative SC-1 exhibit antifibrotic effects through signal transducer and activator of transcription 3 inhibition
|
Su, T.-H. and Shiau, C.-W. and Jao, P. and Liu, C.-H. and Liu, C.-J. and Tai, W.-T. and Jeng, Y.-M. and Yang, H.-C. and Tseng, T.-C. and Huang, H.-P. and Cheng, H.-R. and Chen, P.-J. and Chen, K.-F. and Kao, J.-H. and Chen, D.-S.; Su, Tung-Hung;Shiau, Chung-Wai;Jao, Ping;Liu, Chen-Hua;Liu, Chun-Jen;Tai, Wei-Tien;Jeng, Yung-Ming;Yang, Hung-Chih;Tseng, Tai-Chung;Huang, Hsiang-Po;Cheng, Huei-Ru;Chen, Pei-Jer;Chen, Kuen-Feng;Kao, Jia-Horng;Chen, Ding-Shinn; Su, Tung-Hung;Shiau, Chung-Wai;Jao, Ping;Liu, Chen-Hua;Liu, Chun-Jen;Tai, Wei-Tien;Jeng, Yung-Ming;Yang, Hung-Chih;Tseng, Tai-Chung;Huang, Hsiang-Po;Cheng, Huei-Ru;Chen, Pei-Jer;Chen, Kuen-Feng;Kao, Jia-Horng;Chen, Ding-Shinn; 陳定信;劉振驊;高嘉宏;鄭永銘;楊宏志;蘇東弘;陳昆鋒;劉俊人;陳培哲; 陳定信;劉振驊;高嘉宏;鄭永銘;楊宏志;蘇東弘;陳昆鋒;劉俊人;陳培哲; HUNG-CHIH YANG; Su, Tung-Hung; HSIANG-PO HUANG; Shiau, Chung-Wai; Jao, Ping; CHUN-JEN LIU; Liu, Chen-Hua; PEI-JER CHEN; YUNG-MING JENG; Liu, Chun-Jen; CHEN-HUA LIU; Tai, Wei-Tien; DING-SHINN CHEN; Cheng, Wern-Cherng; Jeng, Yung-Ming; Yang, Hung-Chih; TUNG-HUNG SU; JIA-HORNG KAO; Tseng, Tai-Chung; Huang, Hsiang-Po; Cheng, Huei-Ru; Chen, Pei-Jer; Chen, Kuen-Feng; Kao, Jia-Horng; Chen, Ding-Shinn |
| 臺大學術典藏 |
2018-09-10T15:01:13Z |
Clinical manifestations of central retinal artery occlusion in eyes of proliferative diabetic retinopathy with previous vitrectomy and panretinal photocoagulation
|
Chen, San-Ni;Chao, Chen-Cheng;Hwang, Jiunn-Feng;Yang, Chung-May; Chen, San-Ni;Chao, Chen-Cheng;Hwang, Jiunn-Feng;Yang, Chung-May; 楊中美; Chen, San-Ni; CHUNG-MAY YANG; Wang, Cheng-Yi; Chao, Ting-Ting; Chao, Chen-Cheng; Hwang, Jiunn-Feng; Tai, Wei-Tien; Yang, Chung-May; Chang, Fang-Yu; Su, Wen-Pin; Chen, Yen-Lin; Chen, Pao-Tzu; Weng, Ching-Yu; Yuan, Ang; Shiau, Chung-Wai; Yu, Chong-Jen; Chen, Kuen-Feng; 袁昂; 余忠仁; 陳昆鋒 |
| 臺大學術典藏 |
2018-09-10T14:52:14Z |
Signal transducer and activator of transcription 3 as molecular therapy for non-small-cell lung cancer
|
Chen, Kuen-Feng; Yu, Chong-Jen; Shiau, Chung-Wai; Wang, C.-Y. and Chao, T.-T. and Tai, W.-T. and Chang, F.-Y. and Su, W.-P. and Chen, Y.-L. and Chen, P.-T. and Weng, C.-Y. and Yuan, A. and Shiau, C.-W. and Yu, C.-J. and Chen, K.-F.; Wang, Cheng-Yi;Chao, Ting-Ting;Tai, Wei-Tien;Chang, Fang-Yu;Su, Wen-Pin;Chen, Yen-Lin;Chen, Pao-Tzu;Weng, Ching-Yu;Yuan, Ang;Shiau, Chung-Wai;Yu, Chong-Jen;Chen, Kuen-Feng; 袁昂;余忠仁;陳昆鋒; 袁昂;余忠仁;陳昆鋒; CHONG-JEN YU; Wang, Cheng-Yi; Chao, Ting-Ting; ANG YUAN; Chan, Kuang-Cheng; Tai, Wei-Tien; Chang, Fang-Yu; Su, Wen-Pin; Chen, Yen-Lin; Chen, Pao-Tzu; Weng, Ching-Yu; Yuan, Ang |
| 國立臺灣大學 |
2016 |
Dovitinib Acts As a Novel Radiosensitizer in Hepatocellular Carcinoma by Targeting SHP-1/STAT3 Signaling
|
Huang, Chao-Yuan; Tai, Wei-Tien; Wu, Szu-Yuan; Shih, Chih-Ting; Chen, Min-Hsuan; Tsai, Ming-Hsien; Kuo, Chiung-Wen; Shiau, Chung-Wai; Hung, Man-Hsin; Chen, Kuen-Feng; 黃昭源; 陳昆鋒 |
| 國立臺灣大學 |
2016 |
Disrupting VEGF-A paracrine and autocrine loops by targeting SHP-1 suppresses triple negative breast cancer metastasis
|
Su, Jung-Chen; Mar, Ai-Chung; Wu, Szu-Hsien; Tai, Wei-Tien; Chu, Pei-Yi; Wu, Chia-Yun; Tseng, Ling-Ming; Lee, Te-Chang; Chen, Kuen-Feng; Liu, Chun-Yu; Chiu, Hao-Chieh; Shiau, Chung-Wai; 陳昆鋒; 邱浩傑 |
| 國立臺灣大學 |
2015 |
Sorafenib Action in Hepatitis B Virus X-Activated Oncogenic Androgen Pathway in Liver Through SHP-1
|
Wang, Sheng-Han; Yeh, Shiou-Hwei; Shiau, Chung-Wai; Chen, Kuen-Feng; Lin, Wei-Hsiang; Tsai, Ting-Fen; Teng, Yuan-Chi; Chen, Ding-Shinn; Chen, Pei-Jer; 陳定信; 陳昆鋒; 葉秀慧; 陳培哲 |
| 國立臺灣大學 |
2015 |
Sorafenib and its derivative SC-1 exhibit antifibrotic effects through signal transducer and activator of transcription 3 inhibition
|
Su, Tung-Hung; Shiau, Chung-Wai; Jao, Ping; Liu, Chen-Hua; Liu, Chun-Jen; Tai, Wei-Tien; Jeng, Yung-Ming; Yang, Hung-Chih; Tseng, Tai-Chung; Huang, Hsiang-Po; Cheng, Huei-Ru; Chen, Pei-Jer; Chen, Kuen-Feng; Kao, Jia-Horng; Chen, Ding-Shinn; 陳定信; 劉振驊; 高嘉宏; 鄭永銘; 楊宏志; 蘇東弘; 陳昆鋒; 劉俊人; 陳培哲 |
| 國立臺灣大學 |
2015 |
Treatment of Liver Cancer
|
Liu, Chun-Yu; Chen, Kuen-Feng; Chen, Pei-Jer; 陳昆鋒; 陳培哲 |
| 國立臺灣大學 |
2015 |
Afatinib induces apoptosis in NSCLC without EGFR mutation through Elk-1-mediated suppression of CIP2A
|
Chao, Ting-Ting; Wang, Cheng-Yi; Chen, Yen-Lin; Lai, Chih-Cheng; Chang, Fang-Yu; Tsai, Yi-Ting; Chao, Chung-Hao H.; Shiau, Chung-Wai; Huang, Yuh-Chin T.; Yu, Chong-Jen; Chen, Kuen-Feng; 余忠仁; 陳昆鋒 |
| 國立臺灣大學 |
2014 |
Signal Transducer and Activator of Transcription 3 as Molecular Therapy for Non-Small-Cell Lung Cancer
|
Wang, Cheng-Yi; Chao, Ting-Ting; Tai, Wei-Tien; Chang, Fang-Yu; Su, Wen-Pin; Chen, Yen-Lin; Chen, Pao-Tzu; Weng, Ching-Yu; Yuan, Ang; Shiau, Chung-Wai; Yu, Chong-Jen; Chen, Kuen-Feng; 袁昂; 余忠仁; 陳昆鋒 |
| 國立臺灣大學 |
2014 |
CIP2A mediates erlotinib-induced apoptosis in non-small cell lung cancer cells without EGFR mutation
|
Wang, Cheng-Yi; Chao, Ting-Ting; Chang, Fang-Yu; Chen, Yen-Lin; Tsai, Yi-Ting; Lin, Hen-I; Huang, Yuh-Chin T.; Shiau, Chung-Wai; Yu, Chong-Jen; Chen, Kuen-Feng; 余忠仁; 陳昆鋒 |
| 國立臺灣大學 |
2014 |
TD-19, an Erlotinib Derivative, Induces Epidermal Growth Factor Receptor Wild-Type Nonsmall-Cell Lung Cancer Apoptosis through CIP2A-Mediated Pathway
|
Chao, Ting-Ting; Wang, Cheng-Yi; Lai, Chih-Cheng; Chen, Yen-Lin; Tsai, Yi-Ting; Chen, Pao-Tzu; Lin, Hen-I; Huang, Yuh-Chin T.; Shiau, Chung-Wai; Yu, Chong-Jen; Chen, Kuen-Feng; 余忠仁; 陳昆鋒 |
| 國立臺灣大學 |
2014 |
Development of GADD45 beta (growth arrest DNA damage-inducible gene 45 beta) agonists for the treatment of hepatocellular carcinoma (HCC)
|
Hsu, Chiun; Ou, Da-Liang; Chen, Kuen-Feng; Lin, Zhong-Zhe; Cheng, Ann-Lii; Shiau, Chung-Wai; 林宗哲; 鄭安理; 許駿; 陳昆鋒; 歐大諒 |
| 國立臺灣大學 |
2012 |
CIP2A-mediated Akt activation plays a role in bortezomib-induced apoptosis in head and neck squamous cell carcinoma cells
|
Lin, Yu-Chin; Chen, Kuei-Chiu; Chen, Ching-Chow; Cheng, Ann-Lii; Chen, Kuen-Feng; 鄭安理; 陳昆鋒; 陳青周 |
| 國立臺灣大學 |
2012 |
Activation of tyrosine phosphatase SHP-1 determines the apoptotic effect of sorafenib on HCC cells.
|
Tai, W-T.; Shiau, C-W.; Cheng, A-L.; Chen, P-J.; Chen, K-F.; 陳昆鋒; 陳培哲 |
| 國立臺灣大學 |
2012 |
Novel sorafenib derivatives (SC-40, SC-43 and SC-60) show better anti-tumor effects than sorafenib in hepatocellular carcinoma through SHP-1/STAT3-mediated signaling pathway
|
Tai, Wei-Tien; Shiau, Chung-Wai; Cheng, Ann-Lii; Chen, Pel-Jer; Chen, Kuen-Feng; 鄭安理; 陳昆鋒; 陳培哲 |
| 國立臺灣大學 |
2012 |
Blockade of STAT3 activation by sorafenib derivatives through enhancing SHP-1 phosphatase activity
|
Chen, Kuen-Feng; Tai, Wei-Tien; Hsu, Cheng-Yi; Huang, Jui-Wen; Liu, Chun-Yu; Chen, Pei-Jer; Kim, InKi; Shiau, Chung-Wai; 陳昆鋒; 陳培哲 |
| 國立臺灣大學 |
2012 |
Synthesis and biological activity of obatoclax derivatives as novel and potent SHP-1 agonists
|
Su, Jung-Chen; Chen, Kuen-Feng; Chen, Wei-Lin; Liu, Chun-Yu; Huang, Jui-Wen; Tai, Wei-Tien; Chen, Pei-Jer; Kim, Inki; Shiau, Chung-Wai; 陳昆鋒; 陳培哲 |
| 國立臺灣大學 |
2010 |
Cip2a Mediates Effects of Bortezomib on Phospho-Akt and Apoptosis in Hepatocellular Carcinoma Cells
|
陳昆鋒; 林育靖; 陳培哲; 鄭安理; CHEN, KUEN-FENG; LIN, YU-CHIN; CHEN, PEI-JER; CHENG, ANN-LII |
| 國立臺灣大學 |
2010 |
Sorafenib Overcomes Trail Resistance of Hepatocellular Carcinoma Cells through the Inhibition of Stat3
|
陳昆鋒; 黃祥博; 林育靖; 蕭崇瑋; 陳培哲; 鄭安理; CHEN, KUEN-FENG; HUANG, HSIANG-PO; LIN, YU-CHIN; SHIAU, CHUNG-WAI; CHEN, PEI-JER; CHENG, ANN-LII |
| 國立臺灣大學 |
2010 |
Synergistic Interactions between Sorafenib and Bortezomib in Hepatocellular Carcinoma Involve Pp2a-Dependent Akt Inactivation
|
陳昆鋒; 李水盛; 陳培哲; 鄭安理; CHEN, KUEN-FENG; LEE, SHOEI-SHENG; CHEN, PEI-JER; CHENG, ANN-LII |
| 國立臺灣大學 |
2010 |
Induction of DNA Damage-Inducible Gene Gadd45 Beta Contributes to Sorafenib-Induced Apoptosis in Hepatocellular Carcinoma Cells
|
歐大諒; 沈盈君; 俞松良; 陳昆鋒; 葉培彥; 林亮音; 許駿; 鄭安理; OU DA-LIANG; SHEN YING-CHUN; YU SUNG-LIANG; CHEN KUEN-FENG; YEH PEI-YEN; LIN LIANG-IN; HSU CHIUN; CHENG ANN-LII |
| 國立臺灣大學 |
2009 |
Sorafenib Overcomes Trail Resistance of Hepatocellular Carcinoma Cells through the Inhibition of Signal Transducers and Activators of Transcription 3
|
陳昆鋒; 戴瑋恬; 陳培哲; 鄭安理; CHEN, KUEN-FENG; TAI, WEI-TIEN; CHEN, PEI-JER; CHENG, ANN-LII |
| 國立臺灣大學 |
2009 |
Bortezomib Overcomes Trail Resistance in Hepatocellular Carcinoma Cells in Part through the Inhibition of P13k/Akt Pathway
|
陳昆鋒; 葉培彥; 許駿; 徐志宏; 盧彥伸; 謝興邦; 陳培哲; 鄭安理; CHEN, KUEN-FENG; YEH, PEI-YEN; HSU, CHIUN; HSU, CHIH-HUNG; LU, YEN-SHEN; HSIEH, HSING-PANG; CHEN, PEI-JER; CHENG, ANN-LII |
| 國立臺灣大學 |
2009 |
Bortezomib Overcomes Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand Resistance in Hepatocellular Carcinoma Cells in Part through the Inhibition of the Phosphatidylinositol 3-Kinase/Akt Pathway
|
陳昆鋒; 葉培彥; 許駿; 徐志宏; 盧彥伸; 謝興邦; 陳培哲; 鄭安理; CHEN, KUEN-FENG; YEH, PEI-YEN; HSU, CHIUN; HSU, CHIH-HUNG; LU, YEN-SHEN; HSIEH, HSING-PANG; CHEN, PEI-JER; CHENG, ANN-LII |
显示项目 1-25 / 30 (共2页)
1 2 > >>
每页显示[10|25|50]项目
|
